期刊文献+

腹腔镜子宫肌瘤剔除术与开腹子宫肌瘤切除术治疗子宫肌瘤疗效比较 被引量:55

Comparison of the effect between laparoscopic hysteromyomectomy and abdominal hysteromyomectomy in the treatment of hysteromyoma
在线阅读 下载PDF
导出
摘要 目的比较腹腔镜子宫肌瘤剔除术与开腹子宫肌瘤切除术治疗子宫肌瘤的临床效果。方法选择2015年1月至2017年2月阜宁县人民医院收治的98例子宫肌瘤患者为研究对象,按照手术方法将患者分为腹腔镜手术组和开腹手术组,每组49例。开腹手术组患者行开腹子宫肌瘤切除术,腹腔镜手术组患者行腹腔镜子宫肌瘤剔除术。观察2组患者的手术情况、术后恢复情况及术后并发症,术后第3天采用视觉模拟评分法(VAS)对患者术后疼痛进行评估。所有患者术后随访1 a,观察子宫肌瘤复发情况,并采用生活质量综合评定问卷评估患者生活质量。结果与开腹手术组比较,腹腔镜手术组患者手术时间长,术中出血量少,术后肛门排气时间和住院时间短,VAS评分低(P <0. 05)。腹腔镜手术组和开腹手术组患者术后并发症发生率分别为4. 08%、22. 45%,腹腔镜手术组患者术后并发症发生率低于开腹手术组(P <0. 05)。术后1 a,腹腔镜手术组和开腹手术组患者子宫肌瘤复发率分别为2. 04%、14. 29%,腹腔镜手术组患者子宫肌瘤复发率低于开腹手术组(P <0. 05)。腹腔镜手术组患者的物质生活条件、躯体功能、心理功能、社会功能评分及生活质量总分均高于开腹手术组(P <0. 05)。结论腹腔镜子宫肌瘤剔除术治疗子宫肌瘤创伤小,术后恢复快,且并发症发生率和子宫肌瘤复发率低,患者生活质量高。 Objective To compare the clinical effect of laparoscopic hysteromyomectomy and abdominal hysteromyomectomy in the treatment of hysteromyoma.Methods A total of 98 patients with hysteromyoma in the People′s Hospital of Funing County from January 2015 to February 2017 were selected as the study subjects.The patients were divided into laparoscopic operation group and laparotomy group according to operation method,49 cases in each group.The patients in the laparotomy group were performed with abdominal hysteromyomectomy,while the patients in the laparoscopic operation group underwent laparoscopic hysteromyomectomy.The operation condition,postoperative recovery and postoperative complications of the patients in the two groups were observed.The pain of the patients was evaluated by visual analogue scale(VAS)on the third day after operation.All patients were followed up for one year,and the recurrence of hysteromyoma was observe,the quality of life was assessed by GQOLI-74.Results Compared with the laparotomy group,the operation time was longer,the intraoperative bleeding was less,the postoperative anal exhaust time and hospitalization time were shorter,and the VAS score was lower in the laparoscopic operation group(P<0.05).The incidence of complications in the laparoscopic group and laparotomy group was 4.08%and 22.45%,respectively.The incidence of complications in the laparoscopic group was lower than that in the laparotomy group(P<0.05).Within one year after operation,the recurrence rate of hysteromyoma in the laparoscopic group and laparotomy group was 2.04%and 14.29%,respectively.The recurrence rate of hysteromyoma in the laparoscopic group was lower than that in the laparotomy group(P<0.05).The scores of material life condition,physical function,psychological function,social function and the total score of quality of life in the laparoscopic group were higher than those in the laparotomy group(P<0.05).Conclusion Laparoscopic hysteromyomectomy in the treatment of hysteromyoma has less trauma,faster postoperative recovery,lower complication incidence and hysteromyoma recurrence rate,and higher quality of life.
作者 朱蓉 ZHU Rong(Department of Gynaecology,the People′s Hospital of Funing County,Funing 224400,Jiangsu Province,China)
出处 《新乡医学院学报》 CAS 2018年第12期1094-1096,共3页 Journal of Xinxiang Medical University
关键词 子宫肌瘤 腹腔镜 微创手术 开放手术 子宫肌瘤切除术 hysteromyoma laparoscopy minimally invasive surgery open operation hysteromyomectomy
作者简介 朱蓉(1979-),女,江苏阜宁人,学士,副主任医师,研究方向:妇科腔镜。
  • 相关文献

参考文献8

二级参考文献87

  • 1Filicori M,Hall DA,Loughlin JS,et al.A conservative approach to the management of uterine leiomyoma:pituitary desensibilization by luteinizing hormone releasing hormone analogue[J].Am J Obstet Gynecol,1983,147 (6):726-727.
  • 2Vercellini P,Crosignani PG,Mangioni C,et al.Treatment with gonadotrophin-releasing hormone agonists before hysterectomy for leiomyomas:results of a multicenter randomized controlled trial[J].Br J Obstet Gynaecol,1998,105 (11):1148-1154.
  • 3Di Lieto A,De Falco M,Staibano S,et al.Effects of gonadotropin-releasing hormone agonists on uterine volue and vasculature and on the immunohistochemical expression of basic fibroblast growth factor (bFGF) in uterine leiomyomas[J].Int J Gynecol Pathol,2003,22(4):353-358.
  • 4West CP,Lumsden MA,Baird DT.Goserelin (Zoladex)in the treatment of fibroids[J].Br J Obstet Gynaecol,1992,99 (7):27-30.
  • 5Lethaby A,Vollenhoven B,Sowter M.Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myonmectomy:a systematic review[J].B JOG,2002,109 (10):1097-1108.
  • 6Seracchioli R,Venturoli S,Colombo FM,et al GnRH agonist treatment before total laparoscopic hysterectomy for large uteri[J].J Am Assoc Gynecol Laparosc,2003,10 (3):316-319.
  • 7Di Lieto A,De Falco M,Pollio F,et al.Clinical response,vascular change,and angiogenesis in gonadotropin-releasing hormone analogue-treated women with uterine myomas[J].J Soc Gynecol Investig,2005,12(2):123-128.
  • 8Khan KN,Kitajima M,Hiraki K,et al.Changes in tissue inflammation,angiogenesis and apoptosis in endometriosis,adenomyosis and uterine myoma after GnRH agonist therapy[J].Hum Reprod,2010,25(3):642-653.
  • 9Friedman AJ,Hoffman DI,Comite F,et al.Treatment of leiomyomat uterine with leuprolide acetate depot:a double-blind,placebo-controlled,multicenter study[J].Obstet Gynecol,1991,77 (5):720-725.
  • 10Ichigo S,Takagi H,Matsunami K,et al.Beneficial effects of dienogest on uterine myoma volume:a retrospective controlled study comparing with gonadotropin-releasing hormne agonist[J].Arch Gynecol Obstet,2011,284 (3):667-670.

共引文献316

同被引文献348

二级引证文献364

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部